Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.

Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.

Item
http://www.wikidata.org/entity/Q34347917
Epoxyeicosatrienoic acids and cardioprotection: the road to translationCytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolismStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerHeavy chain single-domain antibodies to detect native human soluble epoxide hydrolaseChemoprevention of metastasisSymmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.Biological evaluation of a novel sorafenib analogue, t-CUPM1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMBDevelopment of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress RespoSoluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.Vascular endothelial growth factor (VEGF), mast cells and inflammation.Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors.Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells
P2860

Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.

Item
http://www.wikidata.org/entity/Q34347917
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@ast
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@en
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@nl
type
label
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@ast
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@en
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@nl
prefLabel
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@ast
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@en
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors
@en
P2093
P2860
P304
P31
P356
10.1016/J.BMCL.2013.05.011
P407
P433
P478
P50
P577
P5875
P698
P932